FiercePharma2h
Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche's Tecentriq
Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it ...
FiercePharma2h
Baxter bolsters IV supplies with imports to address US shortages in wake of Hurricane Helene
Baxter International, which was forced by flooding from Hurricane Helene to temporarily halt production at its North Carolina ...
FiercePharma5h
Otsuka calculates dementia caregivers would earn 6 figures if paid for work
Otsuka has quantified the financial impact of caregivers, calculating that people in the U.S. who look after loved ones with ...
FiercePharma20h
Vanda, despite FDA rejection, swats down another buyout bid from Cycle
The FDA’s rejection of Vanda Pharmaceuticals’ stomach disease candidate has done little to dampen the enthusiasm of England’s ...
FiercePharma21h
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Since Leqembi is dosed based on a patient’s weight and offered in single-use vials, about 5.8% of the drug dispensed will be ...